Deciphera Pharmaceuticals, Inc. EBITDA 2018-2024 | DCPH
Deciphera Pharmaceuticals, Inc. ebitda from 2018 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Deciphera Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-209 |
| 2022 | $-180 |
| 2021 | $-297 |
| 2020 | $-269 |
| 2019 | $-200 |
| 2018 | $-104 |
| 2017 | $-51 |
| 2016 | $-26 |
| 2015 | $-18 |
| Deciphera Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-48 |
| 2023-12-31 | $-51 |
| 2023-09-30 | $-53 |
| 2023-06-30 | $-52 |
| 2023-03-31 | $-53 |
| 2022-12-31 | $-47 |
| 2022-09-30 | $-44 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-46 |
| 2021-12-31 | $-88 |
| 2021-09-30 | $-79 |
| 2021-06-30 | $-70 |
| 2021-03-31 | $-61 |
| 2020-12-31 | $-62 |
| 2020-09-30 | $-63 |
| 2020-06-30 | $-68 |
| 2020-03-31 | $-75 |
| 2019-12-31 | $-70 |
| 2019-09-30 | $-58 |
| 2019-06-30 | $-23 |
| 2019-03-31 | $-49 |
| 2018-12-31 | $-34 |
| 2018-09-30 | $-26 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-22 |
| 2017-12-31 | $-20 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-11 |
| 2017-03-31 | $-8 |
